Feedback / Questions
nepicastat (APL-1401) - Asieris
https://asieris.com/asieris-new-drug-apl-1401-demonstrates-positive-preliminary-results-in-phase-ib-clinical-trial-for-moderately-to-severely-active-uc/
Aug 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next